Researchers at the La Jolla Institute for Allergy and Immunology, in collaboration with colleagues the University of California, San Diego, identified a novel drug target for the treatment of rheumatoid arthritis that focuses on the cells that are directly responsible for the cartilage damage in affected joints.
An early phase study testing an anti-PDL1 agent in combination with standard chemotherapy in the treatment of advanced non-small cell lung cancer has provided promising early results, prompting multiple phase III studies in lung cancer.
A collaborative study led by scientists from the Mechanobiology Institute (MBI) at the National University of Singapore (NUS) has revealed the mechanical forces that drive epithelial wound healing in the absence of cell-supporting environment.
When patients with glaucoma switched from a brand-name drug to its generic counterpart, they were more likely to take their medication as directed compared to those who remained on the brand name drug, according to a study published online in Ophthalmology.
Lyme disease, transmitted by a bite from a tick infected by the Borrelia burgdorferi bacteria, had long been considered easy to treat, usually requiring a single doctors visit and a few weeks of antibiotics for most people.
Bariatric surgery—as a last resort when conservative interventions have failed—can improve liver disease and other obesity-related health problems in severely obese children and adolescents.
For patients with type 1 diabetes (T1D), the burden of constantly monitoring their blood sugar and judging when and how much insulin to self-inject, is bad enough.
The latest breakthrough in amyotrophic lateral sclerosis (ALS) research recently came out of Israel after a leading developer of adult stem cell technologies for neurodegenerative diseases announced positive results from a clinical trial of a potential treatment.
A new intermediate step and unexpected enzymatic activity in a metabolic pathway in the body, which could lead to new drug design for psychiatric and neurodegenerative diseases, has been discovered by researchers at Georgia State University.
In baseball, 3 strikes and youre out. The most common annual vaccine targets 3 strains of flu virus. This year, 2 vaccine strains are spot on and successfully matched. One strain is partially mismatched, but still believed to offer partial coverage for that strain.
